Will the so-called Brexit harm U.K. industrial automation? Not so, say experts, who cite competitive pressures, the ongoing need for trade and technology partners, and desires for negotiated solutions.
International investors spend on Italy’s Gimatic and Germany’s Periscope, Midea encounters resistance in its plan to acquire KUKA, and Foxconn continues hunting for partners.
Pillo is an intelligent home health companion robot that can manage your medications, answer your medical questions, re-order medications, send notifications to family members when medications are missed, and connect you directly with doctors.
Cobots are moving from major automakers to small and midsize enterprises, said Universal Robots’ Scott Mabie at the International Collaborative Robots Workshop.
At MODEX 2016, IAM Robotics demonstrated its Swift autonomous picking robot, which works with its Flash product scanner and SwiftLink fleet management system.
Israel-based Medical Surgery Technologies Ltd. has received Chinese investment and FDA approval for its AutoLap system, an image-guided laparoscope positioning tool to provide robotic surgical assistance.
Companies in this market must expect that new local competitors will emerge — partly supported by the Chinese government.
Danes hold the European title of being most open to the use of robots, yet Danish companies are not fully exploiting the potential of industrial robotics because they lack vital knowledge.
Catch up on a baker’s dozen mergers, acquisitions, and investments that altered the fast-moving robotics industry in the past year.
Researchers, companies heed Prime Minister Shinzo Abe’s call for a robotics revolution, but “Galapagos Syndrome” is still a risk.
A U.K. orthopedics company has acquired Blue Belt, whose Navio robotically controlled device is used in the expanding market for joint replacements.
University of Washington researchers hack an open-source robot, demonstrating vulnerability in all tele-operated robots.
New process allows 3D printed stem cells to be used for drug testing to tailor treatments for people and reduce the dependence of live animal testing.
The growing sophistication of gripping technology has led to heightened competition for the potentially lucrative markets for agricultural and warehouse automation.
Japanese and Chinese companies cooperate to capture a share of the growing industrial automation and service robotics markets.
Berg Health has developed an AI that will allow it to be more “predictive and effective” during the development of its cancer-fighting drug BPM31510 and cut the time to market from 14 years to seven.
Omron is buying Adept, the largest industrial automation provider in the U.S., for $200 million. Both companies stand to gain distribution, and Adept hopes for financial stability.
Gone are the halcyon days of being the Merlin of prototyping and basking in its glow. It?s now all about manufacturing.
Aprecia Pharmaceuticals has created Spritam levetiracetam, a new drug to control seizures brought on by epilepsy, using its “ZipDose” 3D printing technology to create a porous pill that quickly dissolves when taken with a small amount of liquid.
The demand for co-robots in China and Universal Robots’ lead in market share provide incentives for Teradyne’s expansion.
The Rani robotic pill is swallowed like a normal pill and contains tiny needles made of sugar that push into the walls of your intestines and inject medication.
Big time consolidation is rolling into logistics and intralogistics. Just ask Swisslog.
Rethink Robotics announced its Sawyer collaborative robot, a nimbler model than Baxter that is intended for a wide range of automated tasks in global manufacturing.
Maybe brilliant humans working together with brilliant robots will finally and to a finality solve the evasive riddle of this dreaded disease.